Blindsight (Neuralink)

From Wikipedia, the free encyclopedia

Blindsight
InceptionSeptember 2024 Edit this on Wikidata

Blindsight is an experimental medical device developed by Neuralink.[1][2] It has received Breakthrough Device Designation from the US Food and Drug Administration (FDA).[3][4]

See also

References

Related Articles

Wikiwand AI